510(k) device
Irreversible Electroporation Ablation Generator
Zhejiang Curaway Medical Technology Co., Ltd. · Low Energy Direct Current Thermal Ablation System (OAB, Class II) · First FDA decision Jun 8, 2023, newest Jun 8, 2023Tumor ablation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
103
Naming "Irreversible Electroporation"
MAUDE reports
2
Brand "Irreversible Electroporation", since 2015
PubMed studies
1,850
Mentioning "Irreversible Electroporation"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K222001 · Decided Jun 8, 2023 · 336 days after receipt
Device type: Low Energy Direct Current Thermal Ablation System (OAB) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Irreversible Electroporation for CancerLocal determinationIn effectL40205Palmetto GBAUpdated May 14, 2026
- Irreversible Electroporation for CancerProposed local determinationProposedDL40205Palmetto GBAUpdated Sep 19, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "Irreversible Electroporation", any status and sponsor, newest update first.
- Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or AmuletPivotal-lookingActive, not recruiting
Prince of Wales Hospital, Shatin, Hong KongAcademic, hospital or other
NCT05560204 · 200 participants (planned) · Start Jan 1, 2023 · Primary completion Dec 31, 2027
Device: Combined Pulsed-field Ablation (PFA) + Left Atrial Appendage Occlusion (LAAO) · For: Combined Pulsed-field Ablation (PFA)
Sites: Jordon, Hong Kong; Hong Kong, Hong Kong; Taipa, Macau
- Pediatric Adeno-Tonsillar Hypertrophy Treatment Post-Approval StudyNot yet recruiting
ENTire Medical Ltd.Not on our public-company list
NCT07931534 · 73 participants (planned) · Start Nov 5, 2026 · Primary completion May 6, 2028
Device: Irreversible Electroporation · For: Airway Obstruction Upper; Tonsillectomy; Adenoidectomy Surgery and 1 more
Sites: Denver, Colorado; Dallas, Texas
- A Study of the Safety and Effectiveness of a Compound Steep-Pulse Therapy Apparatus for Malignant Liver TumorsPivotal-lookingCompleted
REMD Medical TechnologyNot on our public-company list
NCT07916350 · 181 participants · Start Dec 28, 2021 · Primary completion Jun 26, 2024
Device: Compound Steep-Pulse Therapy Apparatus (HFMP-02); Cool-tip RF Ablation System (CTRF220) · For: Malignant Liver Tumors
Sites: Shanghai, China
Chinese University of Hong KongAcademic, hospital or other
NCT06886321 · 10 participants (planned) · Start Jun 30, 2025 · Primary completion Jan 31, 2027
Device: Prostate Irreversible Electroporation · For: Prostate Cancer
Sites: Hong Kong, Hong Kong
- Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial FibrillationPivotal-lookingCompleted
University Hospital, GrenobleAcademic, hospital or other
NCT05940597 · 354 participants · Start Sep 25, 2023 · Primary completion Mar 23, 2026
Device: Pulse field ablation; Cryoballoon pulmonary vein isolation · For: Atrial Fibrillation Paroxysmal
Sites: Caen, France; Grenoble, France; Montpellier, France · 7 sites in all
First Affiliated Hospital of Zhejiang UniversityAcademic, hospital or other
NCT06867315 · 99 participants (planned) · Start Sep 11, 2024 · Primary completion May 29, 2027
Device: Composite steep-pulse therapeutic device (CNP-III) · For: Benign Prostatic Hyperplasia
Sites: Hefei, China; Fuzhou, China; Quanzhou, China · 10 sites in all
- Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial FibrillationActive, not recruiting
Kardium Inc.Not on our public-company list
NCT05462145 · 549 participants (planned) · Start Mar 9, 2023 · Primary completion Mar 2029
Device: Globe Pulsed Field System · For: Paroxysmal Atrial Fibrillation; Persistent Atrial Fibrillation
Sites: Birmingham, Alabama; Jonesboro, Arkansas; San Francisco, California · 17 sites in all
- Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate CancerPivotal-lookingRecruiting
Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
NCT07548164 · 224 participants (planned) · Start Apr 16, 2026 · Primary completion Apr 16, 2029
Device: NanoKnife System · For: Prostate Cancer
Sites: Basking Ridge, New Jersey; Middletown, New Jersey; Montvale, New Jersey · 8 sites in all
Radboud University Medical CenterAcademic, hospital or other
NCT07779369 · 40 participants (planned) · Start Sep 2026 · Primary completion Sep 2028
Device: Pulsed Field Ablation (PFA) with the VARIPULSE™ catheter · For: Atrial Fibrillation (AF)
- Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)Active, not recruiting
Weill Medical College of Cornell UniversityAcademic, hospital or other
NCT05345444 · 48 participants · Start May 26, 2022 · Primary completion Apr 24, 2026
Device: IRE & MRgRT · For: Prostate Cancer
Sites: New York, New York
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Irreversible Electroporation", and for the whole product code for context.
This brand
2 reports: 1 malfunction, 1 injury, 0 death
Whole product code OAB
114 reports: 47 malfunction, 59 injury, 8 death
Newest reports for this brand
2124215-2025-92263 · Received Dec 22, 2025 · Event dated Nov 21, 2025
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Arrhythmia
2124215-2024-72673 · Received Nov 21, 2024 · Event dated Nov 14, 2024
Device type: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation (QZI)
Device problem as coded: Material Integrity Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Irreversible Electroporation"[tiab]. The summary above synthesizes these.
- Irreversible Electroporation.
Narayanan G · Semin Intervent Radiol · 2015Review
- Irreversible electroporation in radio-recurrent prostate cancer.
Masone MC · Nat Rev Urol · 2023Comment
- SI: Irreversible Electroporation (IRE). Introduction.
Narayanan G · Tech Vasc Interv Radiol · 2015Introductory Journal Article
- Irreversible electroporation for cardiac ablation: Optimizing cell type-specific effects.
Masuyama K, Ajijola OA · J Cardiovasc Electrophysiol · 2022Editorial, Comment
- Irreversible Electroporation for Prostate Cancer.
Ong S, Leonardo M, Chengodu T, et al. · Life (Basel) · 2021Review
- Irreversible electroporation for hepatic tumors.
Pompili M, Francica G · J Ultrasound · 2019Editorial, Comment
- Irreversible Electroporation in Hepatopancreaticobiliary Tumours.
Ruarus AH, Vroomen LGPH, Puijk RS, et al. · Can Assoc Radiol J · 2018Review
- Percutaneous ablation of pancreatic cancer.
D'Onofrio M, Ciaravino V, De Robertis R, et al. · World J Gastroenterol · 2016Editorial, Review
- Irreversible electroporation: Beyond the limits of tumor ablation.
Alonso-González R, Abadal Villayandre JM, Gálvez Gonzalez E, et al. · Radiologia (Engl Ed) · 2024
- Advances in irreversible electroporation for prostate cancer.
Liu X, Wang H, Zhao Z, et al. · Discov Oncol · 2024Review
- Irreversible electroporation: Proceed with caution.
Aras KK, Efimov IR · Heart Rhythm · 2018Editorial, Research Support, N.I.H., Extramural
- Image-guided Ablative Procedures.
Dai R, Uppot R, Arellano R, et al. · Clin Oncol (R Coll Radiol) · 2024Review
Other devices of this type
Also filed under product code OAB.
- NanoKnife Generator (H78720300351US0)Angiodynamics · 510(k) 2026
- Oncobionic System with 6 Probe OutputOncobionics, Inc. · 510(k) 2008
- Steep Pulse Ablation Instrument (including Disposable Sterile Steep Pulse Probe) (SPA-C02)Hangzhou Ruidi Biotechnology , Ltd. · 510(k) 2026
- Aliya® EX SystemGalvanize Therapeutics, Inc. · 510(k) 2026
- Electroporation System (N3000)Surgnova Healthcare Technologies (Zhejiang) Co., Ltd. · 510(k) 2024
- INUMI Flex NeedleGalvanize Therapeutics, Inc. · 510(k) 2024
- Canady Helios Cold Plasma XL-1000CP Ablation System (XL-1000CPSYS)Us Medical Innovations, LLC · 510(k) 2024
- Aliya(TM) System, Aliya(TM) Generator, Aliya(TM) Needle, Aliya(TM) ElectrodeGalvanize Therapeutics, Inc. · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.